Adam Scott Levy Sells $1.25M of Mineralys Therapeutics Inc (MLYS) — SEC Form 4, Jun 13, 2024

Open-Market Net Sale · SEC Form 4

−$1,252,718

10b5-1 Plan

Equity position changed by -27.5%

Reporting Owner

Adam Scott Levy

CFO

TXN 2024-06-11 · FILED 2024-06-13

Equity Position 255K sh 352,277 → 255,462

Equity Change -27.5% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Mineralys Therapeutics Inc

MLYS CIK 0001933414

Reporting Owner

Name	Relationship
Adam Scott Levy CIK 0001693134	CFO

Adam Scott Levy at Mineralys Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $5,709,439

More from this insider at Mineralys Therapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1 F2 F3	2024-06-11	S - Sale 10b5-1	96,815 D	$12.94	-$1,252,718	255,462	Direct

Footnotes (3)

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023. Show more
F2: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.79 to $13.29. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Show more
F3: This balance includes 1,466 shares purchased under the Mineralys Therapeutics, Inc. 2023 Employee Stock Purchase Plan that were not previously reported. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 5 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Mineralys Therapeutics Inc

GET /v1/forms/4/0001933414-24-000027 API docs